{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:10:19Z","timestamp":1789125019215,"version":"build-2803163510"},"reference-count":34,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Background: Colorectal cancer (CRC) is characterized by pronounced genetic and phenotypic heterogeneity, which substantially influences therapeutic response and limits the efficacy of uniform treatment strategies. Cannabinoid-derived phytochemicals and boron-based compounds have independently been reported to modulate cancer cell proliferation, survival, and redox balance. However, the extent to which these agents interact at the cellular level and whether such interactions are dependent on tumor-specific molecular contexts remains poorly defined. Methods: Sodium pentaborate (NaB) was combined with non-cytotoxic concentrations of cannabidiol (CBD) or cannabigerol (CBG) and evaluated in HCT-116 and HT-29 colorectal cancer cell lines. Cell viability and drug interactions were assessed by MTS and combination index analyses. Apoptotic responses were examined by Annexin V\/PI staining, caspase-3\/7 activity assays, and transcriptional profiling of apoptosis-related genes. Cell cycle dynamics and proliferation-associated markers were analyzed by flow cytometry and quantitative PCR. In parallel, ferroptosis-associated gene expression patterns were investigated to evaluate alterations in redox and iron metabolism pathways. Results: NaB\u2013cannabinoid combinations produced divergent biological outcomes depending on cellular background. HT-29 cells exhibited dose-dependent antiproliferative responses to NaB + CBD and NaB + CBG, with synergistic interactions observed only at selected dose combinations accompanied by increased early apoptosis. In contrast, HCT-116 cells primarily responded with cell cycle arrest and transcriptional stress signaling rather than enhanced cytotoxicity. Modulation of ferroptosis-related gene expression further indicated differential redox adaptation between the two cell models. Conclusions: NaB\u2013cannabinoid combinations elicit distinct biological outcomes in colorectal cancer cells that are strongly determined by cellular context. While HT-29 cells are selectively sensitized to combination dose level, HCT-116 cells predominantly respond through cell cycle arrest and adaptive stress-response pathway activation. These findings emphasize the necessity of context-aware combination strategies and provide a mechanistic framework for the further development of boron\u2013cannabinoid-based therapeutic approaches in colorectal cancer.<\/jats:p>","DOI":"10.3390\/molecules31183206","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:51:37Z","timestamp":1789123897000},"page":"3206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing Anti-Cancer Efficacy in Colorectal Cancer Through Cannabinoid and Sodium Pentaborate Co-Therapy"],"prefix":"10.3390","volume":"31","author":[{"given":"B\u00fc\u015fra","family":"Y\u00fcksel","sequence":"first","affiliation":[{"name":"Department of Genetics and Bioengineering, Faculty of Engineering Natural Science, Yeditepe University, Kay\u0131\u015fda\u011f\u0131, Istanbul 34755, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"given":"Fikrettin","family":"\u015eahin","sequence":"additional","affiliation":[{"name":"Department of Genetics and Bioengineering, Faculty of Engineering Natural Science, Yeditepe University, Kay\u0131\u015fda\u011f\u0131, Istanbul 34755, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-7282","authenticated-orcid":false,"given":"Nezaket","family":"T\u00fcrkel","sequence":"additional","affiliation":[{"name":"Department of Genetics and Bioengineering, Faculty of Engineering Natural Science, Yeditepe University, Kay\u0131\u015fda\u011f\u0131, Istanbul 34755, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","first-page":"153","article-title":"Colorectal carcinoma: Pathologic aspects","volume":"3","author":"Fleming","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_2","first-page":"233","article-title":"Colorectal cancer statistics","volume":"73","author":"Mph","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Molinari, C., Marisi, G., Passardi, A., Matteucci, L., De Maio, G., and Ulivi, P. (2018). Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123733"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-022-00922-2","article-title":"Colorectal liver metastasis: Molecular mechanism and interventional therapy","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1758835919866362","DOI":"10.1177\/1758835919866362","article-title":"Opportunities for cannabis in supportive care in cancer","volume":"11","author":"Kleckner","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kis, B., Ifrim, F.C., Buda, V., Avram, S., Pavel, I.Z., Antal, D., Paunescu, V., Dehelean, C.A., Ardelean, F., and Diaconeasa, Z. (2019). Cannabidiol\u2014From Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235905"},{"key":"ref_7","first-page":"3799","article-title":"Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent","volume":"31","author":"Manuscript","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11481-015-9608-y","article-title":"The antitumor activity of plant-derived non-psychoactive cannabinoids","volume":"10","author":"Mcallister","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acsptsci.4c00644","article-title":"Cannabidiol Targets Colorectal Cancer Cells via Cannabinoid Receptor 2, Independent of Common Mutations","volume":"8","author":"Wong","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_10","first-page":"1029","article-title":"WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPAR c","volume":"19","author":"Pellerito","year":"2014","journal-title":"Apoptosis"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Li, D., Ilnytskyy, Y., Gojani, E.G., Kovalchuk, O., and Kovalchuk, I. (2022). Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts. Molecules, 27.","DOI":"10.3390\/molecules27186057"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, S., Li, W., Malhi, N.K., Huang, J., Li, Q., Zhou, Z., Wang, R., Peng, J., Yin, T., and Wang, H. (2024). Cannabigerol ( CBG ): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules, 29.","DOI":"10.3390\/molecules29225471"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fikrettin, \u015e. (2023). Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1145666"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/advances\/nmz110","article-title":"Boron","volume":"11","author":"Nielsen","year":"2020","journal-title":"Adv. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejmech.2019.06.092","article-title":"Boron in drug design: Recent advances in the development of new therapeutic agents","volume":"179","author":"Felipe","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Frooman, M.B., Deb, M.K., Peters, J., Leggett, S., Sanghai, N., Rizvi, N.Z., Atukorallaya, D., and Tranmer, G.K. (2025). Recent Advancements in the Diversification and Applications of Boron-Containing Compounds in Medicinal Chemistry. Pharmaceuticals, 18.","DOI":"10.3390\/ph18121798"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1007\/s12011-023-03632-0","article-title":"Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms","volume":"201","author":"Mohammed","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105137","DOI":"10.1016\/j.neuint.2021.105137","article-title":"Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies","volume":"149","author":"Turkez","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"126923","DOI":"10.1016\/j.jtemb.2022.126923","article-title":"Anti-cancer effect of boron derivatives on small-cell lung cancer","volume":"70","author":"Cebeci","year":"2022","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.1038\/ncomms13936","article-title":"Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment","volume":"7","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12011-019-01738-y","article-title":"Suppressor Effects of Sodium Pentaborate Pentahydrate and Pluronic F68 on Adipogenic Differentiation and Fat Accumulation","volume":"193","author":"Yilmaz","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-016-2719-9","article-title":"Boron promotes streptozotocin-induced diabetic wound healing: Roles in cell proliferation and migration, growth factor expression, and inflammation","volume":"417","author":"Demirci","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sahin, F. (2025). Targeting Hippo Signaling Pathway with a Boron Derivative, Sodium Pentaborate Pentahydrate (NaB): Therapeutic Strategies in Colorectal Cancer. Pharmaceuticals, 18.","DOI":"10.3390\/ph18081171"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1038\/oncsis.2013.35","article-title":"Epigenetic and genetic features of 24 colon cancer cell lines","volume":"2","author":"Ahmed","year":"2013","journal-title":"Oncogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Perspective Mutant p53 in Cancer: New Functions and Therapeutic Opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Viereckl, M.J., Krutsinger, K., Apawu, A., Gu, J., Cardona, B., Barratt, D., and Han, Y. (2022). Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules, 12.","DOI":"10.3390\/biom12060854"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.1038\/s41598-024-66599-5","article-title":"Cannabidiol effectively prevents oxidative stress and stabilizes hypoxia-inducible factor-1 alpha (HIF-1\u03b1) in an animal model of global hypoxia","volume":"14","author":"Kletkiewicz","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jtcme.2024.04.007","article-title":"Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K\/AKT\/mTOR pathway","volume":"14","author":"Pongking","year":"2024","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12011-019-01739-x","article-title":"High Concentrations of Boric Acid Trigger Concentration-Dependent Oxidative Stress, Apoptotic Pathways and Morphological Alterations in DU-145 Human Prostate Cancer Cell Line","volume":"193","author":"Hacioglu","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_30","first-page":"273","article-title":"Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Conrad","year":"2018","journal-title":"Ferroptosis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12935-025-03641-0","article-title":"Application prospects of ferroptosis in colorectal cancer","volume":"25","author":"Yang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mahemuti, D., Ma, L., Siddiqe, W., Tang, Z., Kong, Y., Li, W., Zhang, Z., Su, Z., and Maimaitijiang, A. (2026). Ferroptosis as a novel therapeutic strategy to overcome multidrug resistance in colorectal cancer. Pharmaceuticals, 19.","DOI":"10.3390\/ph19020252"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","article-title":"Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Li, Y., Bi, Y., Li, W., Piao, Y., Piao, J., Wang, T., and Ren, X. (2024). Research progress on ferroptosis in colorectal cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1462505"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/18\/3206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:52:21Z","timestamp":1789123941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/18\/3206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":34,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["molecules31183206"],"URL":"https:\/\/doi.org\/10.3390\/molecules31183206","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}